Table 2.

Engraftment and GVHD

	HLA 10/10	HLA 9/10	HLA 8/10	p value
Total number of patients	2567	723	108
Engraftment, n (%)	2458 (97.3 %)	678 (96.3 %)	101 (97.12 %)	0.313
No engraftment, n (%)	67 (2.7 %)	26 (3.7 %)	3 (2.9 %)
Missing, n	42	19	5
Median time ANC >0.5 G/L (days, range)	16 (0–103)	16 (1–165)	15.5 (1–33)	0.538
Acute GVHD,
Grade 0–I, n (%)	1826 (74.4 %)	469 (67.2 %)	67 (65.7 %)	0.0002
Grades II–IV, n (%)	629 (25.6 %)	229 (32.8 %)	35 (34.3 %)
Grades III–IV, n (%)	234 (9.5 %)	90 (12.9 %)	11 (10.8 %)	0.035
Missing, n	75	21	3
Chronic GVHDa
All grades	35.0 % [32.9–37.2]	35.1 % [31.2–39]	44.4 % [33.6–54.6]	0.138
Extensive	17.1 % [15.4–18.9]	15.2 % [12.3–18.5]	26.1 % [16.8–36.4]	0.047
Limited, n	369	109	14
Extensive, n	324	80	21
Missing, n	38	18	5

GVHD graft-versus-host disease

^aTwo-year cumulative incidence